Gary Chmielewski to Abnormalities, Drug-Induced
This is a "connection" page, showing publications Gary Chmielewski has written about Abnormalities, Drug-Induced.
Connection Strength
0.349
-
Micro-CT imaging: Developing criteria for examining fetal skeletons in regulatory developmental toxicology studies - A workshop report. Regul Toxicol Pharmacol. 2016 Jun; 77:100-8.
Score: 0.131
-
Juvenile toxicity assessment of anidulafungin in rats: an example of navigating case-by-case study design through scientific and regulatory challenges. Birth Defects Res B Dev Reprod Toxicol. 2011 Aug; 92(4):333-44.
Score: 0.094
-
Embryo-fetal developmental toxicity of figitumumab, an anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody, in cynomolgus monkeys. Birth Defects Res B Dev Reprod Toxicol. 2010 Aug; 89(4):326-38.
Score: 0.089
-
Comparison of rat and rabbit embryo-fetal developmental toxicity data for 379 pharmaceuticals: on the nature and severity of developmental effects. Crit Rev Toxicol. 2016 11; 46(10):900-910.
Score: 0.034